Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1191 participants.

Also called NCT01556126

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,191 participants (enrolled count) (from the registry)
Sponsor
CID - Carbostent & Implantable Devices (from the registry)
Registry
  • NCT NCT01556126
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Belgium, Italy, Netherlands, Norway, Poland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01556126. Allocation not applicable; no masking; primary purpose treatment. Start 2012-02 (actual); primary completion 2014-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
Acronym
PARTICIPATE
Condition
Stable Angina
Condition
Unstable Angina
Condition
Acute Myocardial Infarction
Intervention (Device)
Amphilimus Eluting Stent (CRE8)
Lead sponsor
CID - Carbostent & Implantable Devices (class: industry)

Record details

Record id
cardio:ct-nct01556126
Content hash
77804d872f2c14a53ad478bba095837792cd96427320ba38db1523b4e1c7e6af